Form 4 Tracker
Cullinan Therapeutics, Inc.
CGEM

26 insider filings · Latest: Jun 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 5, 2026May 6 9:00 PMJennifer MichaelsonChief Scientific Officer
Sale
8,000$14.62$117.0K166,844(D)

View →

May 5, 2026May 5 8:34 PMJENNIFER MICHAELSON
Proposed Sale
8,000$15.34$122.7K

View →

Mar 5, 2026Mar 9 9:00 PMJennifer MichaelsonChief Scientific Officer
Sale
8,000$15.68$125.4K170,844(D)

View →

Mar 5, 2026Mar 5 9:31 PMJENNIFER MICHAELSON
Proposed Sale
8,000$16.30$130.4K

View →

Feb 25, 2026Feb 26 10:05 PMJennifer MichaelsonChief Scientific Officer
Sale
1,780$14.14$25.2K174,844(D)

View →

Feb 24, 2026Feb 25 10:00 PMJennifer MichaelsonChief Scientific Officer
Sale
3,601$14.47$52.1K176,624(D)

View →

Feb 23, 2026Feb 25 10:00 PMJennifer MichaelsonChief Scientific Officer
Sale
1,752$13.99$24.5K180,225(D)

View →

Feb 24, 2026Feb 25 10:00 PMNadim AhmedDirector, President and CEO
Sale
13,515$14.47$195.6K390,803(D)

View →

Feb 24, 2026Feb 25 10:00 PMJeffrey Alan JonesChief Medical Officer
Sale
4,582$14.47$66.3K159,968(D)

View →

Feb 24, 2026Feb 25 10:00 PMJacquelyn L SumerChief Legal Officer
Sale
3,601$14.47$52.1K128,089(D)

View →

Feb 25, 2026Feb 25 9:33 PMJENNIFER MICHAELSON
Proposed Sale
1,780$14.27$25.4K

View →

Feb 20, 2026Feb 23 10:00 PMJeffrey Alan JonesChief Medical Officer
Sale
4,982$13.62$67.9K164,550(D)

View →

Feb 20, 2026Feb 23 10:00 PMJennifer MichaelsonChief Scientific Officer
Sale
11,742$14.08$165.4K181,977(D)

View →

Feb 20, 2026Feb 23 10:00 PMJacquelyn L SumerChief Legal Officer
Sale
3,742$13.62$51.0K131,690(D)

View →

Feb 20, 2026Feb 23 10:00 PMNadim AhmedDirector, President and CEO
Sale
16,381$13.62$223.1K404,318(D)

View →

Feb 20, 2026Feb 23 10:00 PMMary Kay FentonChief Financial Officer
Sale
4,398$13.62$59.9K126,380(D)

View →

Feb 23, 2026Feb 23 9:31 PMJENNIFER MICHAELSON
Proposed Sale
1,752$13.65$23.9K

View →

Feb 20, 2026Feb 20 9:27 PMJENNIFER MICHAELSON
Proposed Sale
8,000$13.88$111.0K

View →

Feb 12, 2026Feb 13 10:00 PMJennifer MichaelsonChief Scientific Officer
Sale
416$12.03$5.0K128,219(D)

View →

Jan 22, 2026Jan 23 10:00 PMJennifer MichaelsonChief Scientific Officer
Sale
4,000$12.30$49.2K128,635(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 16, 2026Jun 18 9:00 PMAnthony RosenbergDirector
Grant/Award
25,319$13.5525,319(D)

View →

Jun 16, 2026Jun 18 9:00 PMDavid D. MeekDirector
Grant/Award
25,319$13.5525,319(D)

View →

Jun 16, 2026Jun 18 9:00 PMStephen W WebsterDirector
Grant/Award
25,319$13.5525,319(D)

View →

Jun 16, 2026Jun 18 9:00 PMAndrew R AllenDirector
Grant/Award
21,781$13.5521,781(D)

View →

Jun 16, 2026Jun 18 9:00 PMMary ThistleDirector
Grant/Award
25,319$13.5525,319(D)

View →

Jun 16, 2026Jun 18 9:00 PMMittie DoyleDirector
Grant/Award
21,781$13.5521,781(D)

View →

May 5, 2026May 6 9:00 PMJennifer MichaelsonChief Scientific Officer
Option Exercise
4,000$4.30116,987(D)

View →

Mar 5, 2026Mar 9 9:00 PMJennifer MichaelsonChief Scientific Officer
Option Exercise
4,000$4.30120,987(D)

View →

Feb 20, 2026Feb 23 10:00 PMJennifer MichaelsonChief Scientific Officer
Option Exercise
8,000$4.30124,987(D)

View →

Feb 18, 2026Feb 19 10:00 PMJacquelyn L SumerChief Legal Officer
Grant/Award
230,000$12.44230,000(D)

View →

Feb 18, 2026Feb 19 10:00 PMJeffrey Alan JonesChief Medical Officer
Grant/Award
300,000$12.44300,000(D)

View →

Feb 18, 2026Feb 19 10:00 PMNadim AhmedDirector, President and CEO
Grant/Award
828,000$12.44828,000(D)

View →

Feb 18, 2026Feb 19 10:00 PMCorrine SavillChief Business Officer
Grant/Award
175,000$12.44175,000(D)

View →

Feb 18, 2026Feb 19 10:00 PMMary Kay FentonChief Financial Officer
Grant/Award
137,500$12.44137,500(D)

View →

Feb 18, 2026Feb 19 10:00 PMJennifer MichaelsonChief Scientific Officer
Grant/Award
115,000$12.44115,000(D)

View →